Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Eda Caliskan, Yildirim"'
Autor:
Mehmet Uzun, Elif Atag, Eda Caliskan Yildirim, Murat Keser, Huseyin Salih Semiz, Olcun Umit Unal
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Biomarkers such as hormone receptors (HR) and human epidermal growth factor receptor2 (HER2) may change after neoadjuvant chemotherapy (NAC) in breast cancer patients. The aim of this study was to investigate the rates of receptor change aft
Externí odkaz:
https://doaj.org/article/d7ddd3ddd7f245d98d03a79420554f9d
Autor:
Eda Caliskan Yildirim, Elif Atag, Ezgi Coban, Olcun Umit Unal, Abdussamet Celebi, Murat Keser, Mehmet Uzun, Merve Keskinkilic, Eda Tanrikulu Simsek, Murat Sari, Tugba Yavuzsen
Publikováno v:
Breast, Vol 70, Iss , Pp 56-62 (2023)
Background: CDK4/6 inhibitors combined with endocrine therapy have significantly improved treatment outcomes for metastatic hormone receptor-positive (HR+) breast cancer patients. However, the impact of low HER2 expression on treatment response and p
Externí odkaz:
https://doaj.org/article/968ed83daa7545e0b6b5f0347defa3cf
Autor:
Huseyin Salih Semiz, Erdem Kisa, Eda Caliskan Yildirim, Elif Atag, Mehmet Emin Arayici, Talha Muezzinoglu, Aziz Karaoglu
Publikováno v:
Turkish Journal of Urology, Vol 48, Iss 4, Pp 287-293 (2022)
Externí odkaz:
https://doaj.org/article/9f12af2bddda42f2a541d801c1f67f3d
Publikováno v:
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP. 32(11)
To evaluate the effect of pretreatment C-reactive protein (CRP)/Albumin ratio (CAR) on prognosis and its association with IMDC (International metastatic renal cell carcinoma database consortium) risk score and overall survival (OS) in metastatic rena
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7aa85bfeeea8ce73c6034ac53c1e5f56
https://pubmed.ncbi.nlm.nih.gov/36377009
https://pubmed.ncbi.nlm.nih.gov/36377009
Autor:
Alev Turker, Cem Çöteli, Emre Gedik, Deniz Yuce, Aysegul Uner, Necla Ozer, Eda Caliskan Yildirim, Gurcan Gunaydin
No biomarker is currently available for early detection of anthracycline-induced cardiotoxicity. The purpose of this study was to assess whether the plasma levels of microRNA34a (miR34a) could predict cardiotoxicity in breast cancer patients who rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c12c74e7da5be8997a1f4e35737eb984
https://doi.org/10.21203/rs.3.rs-962788/v1
https://doi.org/10.21203/rs.3.rs-962788/v1
Autor:
Gokhan Ucar, Merve Dirikoc, Oznur Bal, Nadiye Akdeniz, Yusuf Acikgoz, Eda Caliskan Yildirim, Yakup Ergun, Dogan Uncu
Background: In this study, we aimed to investigate the frequency, prognostic effect of codon, and amino acid-specific KRAS mutations in patients with metastatic colorectal cancer (mCRC) and their predictive effect on irinotecan and oxaliplatin during
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::443cac12e08921bdd25c4f279bb6061d
https://avesis.deu.edu.tr/publication/details/3b1f9707-a3a9-4863-b330-0f07f54f0b6e/oai
https://avesis.deu.edu.tr/publication/details/3b1f9707-a3a9-4863-b330-0f07f54f0b6e/oai